Work

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Refractory / Relapsed AML

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.3731.3731

Authors: Adolfo Diaz Duque, Jasleen Randhawa, Hagop M. Kantarjian, Naveen Pemmaraju, Elias Jabbour, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Marina Konopleva, Farhad Ravandi, Yesid Alvarado, Varsha Gandhi, Gautam Borthakur, Jorge E. Cortes

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2563294958

FWCI:

Cites:

Cited by:

Related to: 10